123 related articles for article (PubMed ID: 18353413)
1. Proteomic and metabolomic biomarkers for III-V semiconductors: and prospects for application to nano-materials.
Fowler BA; Conner EA; Yamauchi H
Toxicol Appl Pharmacol; 2008 Nov; 233(1):110-5. PubMed ID: 18353413
[TBL] [Abstract][Full Text] [Related]
2. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of human populations for early markers of cadmium toxicity: a review.
Fowler BA
Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
[TBL] [Abstract][Full Text] [Related]
4. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinurias.
Fowler BA; Conner EA; Yamauchi H
Toxicol Appl Pharmacol; 2005 Aug; 206(2):121-30. PubMed ID: 15967200
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
8. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
9. The application of SELDI-TOF mass spectrometry to mammalian cell culture.
Woolley JF; Al-Rubeai M
Biotechnol Adv; 2009; 27(2):177-84. PubMed ID: 19049820
[TBL] [Abstract][Full Text] [Related]
10. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
[TBL] [Abstract][Full Text] [Related]
11. SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
[TBL] [Abstract][Full Text] [Related]
12. Biological indicators for monitoring exposure/toxicity from III-V semiconductors.
Conner EA; Yamauchi H; Fowler BA; Akkerman M
J Expo Anal Environ Epidemiol; 1993; 3(4):431-40. PubMed ID: 8173343
[TBL] [Abstract][Full Text] [Related]
13. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry.
Park JS; Oh KJ; Norwitz ER; Han JS; Choi HJ; Seong HS; Kang YD; Park CW; Kim BJ; Jun JK; Syn HC
Reprod Sci; 2008 May; 15(5):457-68. PubMed ID: 18579854
[TBL] [Abstract][Full Text] [Related]
14. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
Issaq HJ; Waybright TJ; Veenstra TD
Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
[TBL] [Abstract][Full Text] [Related]
15. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
[TBL] [Abstract][Full Text] [Related]
16. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
17. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
18. Generally detected proteins in comparative proteomics--a matter of cellular stress response?
Wang P; Bouwman FG; Mariman EC
Proteomics; 2009 Jun; 9(11):2955-66. PubMed ID: 19415655
[TBL] [Abstract][Full Text] [Related]
19. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
20. Proteomics in atherothrombosis: a future perspective.
Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
